Grant Pickering Vaxcyte, Inc. (PCVX) insider trading activity

Grant Pickering is CHIEF EXECUTIVE OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 450,301 shares of PCVX, which is worth approximately $36.5 Million. The most recent transaction as insider was on Jun 22, 2021, when has been sold 74 shares (Common Stock) at a price of $1.79 per share, resulting in proceeds of $132. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 450K

3.21% 3M change

19.82% 12M change

Total Value Held $36.5 Million

GRANT PICKERING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 22 2021	BUY Exercise of conversion of derivative security	$132 $1.79 p/Share	74 Added 0.01%	580,328 Common Stock
Jun 21 2021	SELL Open market or private sale	$23,439 $22.05 p/Share	1,063 Reduced 0.18%	580,254 Common Stock
Jun 21 2021	BUY Exercise of conversion of derivative security	$1,903 $1.79 p/Share	1,063 Added 0.18%	581,317 Common Stock
Jun 04 2021	SELL Open market or private sale	$179,179 $22.14 p/Share	8,093 Reduced 1.38%	580,254 Common Stock
Jun 04 2021	BUY Exercise of conversion of derivative security	$14,486 $1.79 p/Share	8,093 Added 1.36%	588,347 Common Stock
Jun 03 2021	SELL Open market or private sale	$154,881 $22.11 p/Share	7,005 Reduced 1.19%	580,254 Common Stock
Jun 03 2021	BUY Exercise of conversion of derivative security	$12,539 $1.79 p/Share	7,005 Added 1.18%	587,259 Common Stock
May 28 2021	SELL Open market or private sale	$58,857 $22.16 p/Share	2,656 Reduced 0.46%	580,254 Common Stock
May 28 2021	BUY Exercise of conversion of derivative security	$4,754 $1.79 p/Share	2,656 Added 0.45%	582,910 Common Stock
May 27 2021	SELL Open market or private sale	$270,637 $22.1 p/Share	12,246 Reduced 2.07%	580,254 Common Stock
May 27 2021	BUY Exercise of conversion of derivative security	$21,920 $1.79 p/Share	12,246 Added 2.02%	592,500 Common Stock
Mar 19 2021	SELL Open market or private sale	$386,550 $25.77 p/Share	15,000 Reduced 2.53%	578,691 Common Stock
Mar 19 2021	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.46%	593,691 Common Stock
Feb 22 2021	SELL Open market or private sale	$397,500 $26.5 p/Share	15,000 Reduced 2.53%	578,691 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.46%	593,691 Common Stock
Jan 19 2021	SELL Open market or private sale	$381,600 $25.44 p/Share	15,000 Reduced 2.53%	578,691 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.46%	593,691 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$9,845 $1.79 p/Share	5,500 Added 0.94%	578,691 Common Stock
Dec 21 2020	SELL Open market or private sale	$436,950 $29.13 p/Share	15,000 Reduced 2.55%	573,191 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.49%	588,191 Common Stock

Also insider at

ATHA

Athira Pharma, Inc. Healthcare

Grant Pickering

CHIEF EXECUTIVE OFFICER

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account